Comparison of Reduced-Intensity Idarubicin and Daunorubicin Plus Cytarabine as Induction Chemotherapy for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia
Crossref DOI link: https://doi.org/10.1007/s40261-016-0469-9
Published Online: 2016-10-08
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Hui
Fu, Rong
Li, Lijuan
Wang, Guojin
Song, Jia
Ruan, Erbao
Wang, Huaquan
Wu, Yuhong
Wang, Xiaoming
Ding, Kai
Shao, Zonghong
License valid from 2016-10-08